CD274 and neoplasm: Current evidence has proposed several approaches by which intrinsic DDR deficiency manipulated tumor immunophenotypes, including activation of immune response through cytosolic DNA sensing pathways or cell death signals, enhancement of tumor immunogenicity by increasing tumor mutations and genome instability, and reshaping local tumor immune microenvironments by regulating key immune checkpoint molecules (e.g., PD‐L1).3